[肼屈嗪（ISF 2469）对水钠平衡及原发性高血压的影响] - Suppr | 超能文献

[Effects of cadralazine (ISF 2469) on water-sodium balance and on essential arterial hypertension].

作者信息

Lavezzaro G C, Gastaldo D, Noussan P, Bensoni M, Parini J, Angelino P F

出版信息

Minerva Cardioangiol. 1981 Oct;29(10):527-34.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Effects of cadralazine (ISF 2469) on water-sodium balance and on essential arterial hypertension].[肼屈嗪（ISF 2469）对水钠平衡及原发性高血压的影响]

Minerva Cardioangiol. 1981 Oct;29(10):527-34.

2

[Open pilot study of the activity and tolerability of cadralazine in hypertensive patients resistant to other therapy].

Minerva Cardioangiol. 1982 Mar;30(3):69-74.

3

[Behavior of arterial pressure, hemodynamic parameters, sympathetic nervous system activity and plasma volume during treatment with a vasodilating and beta-blocking drug in essential hypertension patients].

Boll Soc Ital Cardiol. 1981;26(11):1871-4.

4

[Clinical pharmacology of a new hypotensive drug with peripheral vasodilating action (ISF 2123); effects of acute intravenous administration in hypertensive patients].[一种具有外周血管舒张作用的新型降压药物（ISF 2123）的临床药理学；对高血压患者急性静脉给药的效果]

Boll Soc Ital Cardiol. 1977;22(7):1053-6.

5

Repetitive dosing of intravenous levosimendan improves pulmonary hemodynamics in patients with pulmonary hypertension: results of a pilot study.静脉注射左西孟旦重复给药可改善肺动脉高压患者的肺血流动力学：一项初步研究的结果。

J Clin Pharmacol. 2009 Jan;49(1):109-15. doi: 10.1177/0091270008325150. Epub 2008 Nov 3.

6

Hemodynamic effects of cadralazine or chlorthalidone in verapamil-treated elderly hypertensives.卡屈嗪或氯噻酮对维拉帕米治疗的老年高血压患者的血流动力学影响。

Int J Clin Pharmacol Ther. 1994 Apr;32(4):198-203.

7

[Effects on long-term treatment with indapamide in subjects with essential arterial hypertension].[吲达帕胺对原发性高血压患者的长期治疗效果]

Clin Ter. 1981 May 31;97(4):405-10.

8

[Effect of a new derivative of 3-hydrazine pyridazine: ISF 2123 in hypertensive patients. Note 2].[3-肼基哒嗪的一种新衍生物：ISF 2123对高血压患者的影响。注释2]

Minerva Cardioangiol. 1975 Dec;23(12):901-5.

9

[Activity of a new derivative of 3-hydrazinopyridazine: ISF 2123 in patients with hypertension. I].[3-肼基哒嗪的一种新衍生物ISF 2123在高血压患者中的活性。I]

Minerva Cardioangiol. 1975 Nov;23(11):735-47.

10

[Effect of the long-term administration of verapamil on arterial pressure and water-salt balance in hypertensive patients].

Boll Soc Ital Cardiol. 1978;23(10):1773-8.

引用本文的文献

1

Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension.卡屈嗪作为治疗高血压第二步用药的对照临床试验。

Eur J Clin Pharmacol. 1985;28(2):135-8. doi: 10.1007/BF00609680.

2

Cadralazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.卡屈嗪。对其药效学和药代动力学特性以及在高血压治疗中的治疗潜力的综述。

Drugs. 1990 Oct;40(4):543-60. doi: 10.2165/00003495-199040040-00005.